Compare RYTM & REYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYTM | REYN |
|---|---|---|
| Founded | 2008 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.9B |
| IPO Year | 2017 | 2019 |
| Metric | RYTM | REYN |
|---|---|---|
| Price | $82.62 | $20.73 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 6 |
| Target Price | ★ $131.14 | $24.83 |
| AVG Volume (30 Days) | 505.0K | ★ 1.0M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 4.47% |
| EPS Growth | ★ 28.34 | N/A |
| EPS | N/A | ★ 1.43 |
| Revenue | N/A | ★ $3,756,000,000.00 |
| Revenue This Year | $55.34 | $1.91 |
| Revenue Next Year | $86.06 | $1.82 |
| P/E Ratio | ★ N/A | $14.65 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $55.31 | $20.44 |
| 52 Week High | $122.20 | $26.25 |
| Indicator | RYTM | REYN |
|---|---|---|
| Relative Strength Index (RSI) | 39.88 | 40.73 |
| Support Level | $74.50 | $20.70 |
| Resistance Level | $90.79 | $24.99 |
| Average True Range (ATR) | 3.24 | 0.49 |
| MACD | -0.28 | -0.05 |
| Stochastic Oscillator | 23.60 | 14.42 |
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.
Reynolds Consumer Products Inc is a provider of household products. The firm is engaged in the production and sales of cooking products, waste and storage products, and tableware. It operates through four reportable segments namely, Reynolds Cooking and Baking, Hefty Waste and Storage, Hefty Tableware, and Presto Products. Reynolds Cooking and Baking segment produce branded and store brand aluminum foil, disposable aluminum pans, parchment paper, freezer paper, wax paper, butcher paper, plastic wrap, baking cups, oven bags and slow cooker liners.